Today’s news reports deal with:
- Diabetes, PSA, and prostate cancer risk
- Magnetic resonance spectroscopic imaging
- Ongoing trials of dutasteride as early stage treatment for prostate cancer … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment, Uncategorized | Tagged: ARTS, diabetes, dutasteride, magmentic resonance spectroscopic imaging, MSRI, REDEEM, risk | Leave a comment »